|
January 2, 2002 I am adding some new material to the Turnertoys presentation on ADHD, focusing on the theories of Russel Barkeley, Professor of Neurology and Psychiatry at the University of Massachussetts Medical Center. He takes pretty the opposite position to that of Peter Breggin (for whom I provide sources and links below). Breggin sees ADHD primarily as a normal response of children to the situations in which they find themselves, as well as a symptom of a society that finds it easier to control children chemically than try to understand why they behave as they do, and also a result of faulty and indescriminate diagnosis. Barkley has elaborated a theory of ADHD as a neurophysiological deficit in children afflicted with it, and has defined the identifying symptoms in a formal, theoretical way. Below are my discoveries in the literature and my speculations as of a year ago.
4/22/06: This material is now embarassingly out of date, pending addition of
material already written. Maybe you shouldn't read it. Check back in a month or two or
three.
|
|
November 12, 2000 Ed Loewenton |
|
A Brief History (Another perspective
- new materials) By the mid-1980's, the cluster of symptoms was being officially referred to as ADHD, and diagnostic standards had been formalized in the American Psychiatric Association's (APA) Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. (DSM-III). In 1995, 10 to 12 pecent of all boys between the ages of 6 and 14 in the U.S. were diagnosed with ADHD and were being treated with Ritalin. Presently, the diagnostic standards are those found in DSM-IV, published in 1994. The number of children diagnosed and treated for Attention Deficit Hyperactivity Disorder now stands at about 5 million, according to one estimate. A study in North Carolina found that 10% of children were receiving stimulant drugs at home or in school. As many as 15% of boys between the ages of 6 and 14 in the U.S. have been diagnosed with ADHD and are receiving drug therapy. The United States now consumes about 90% of world Ritalin production. Three variations of ADHD are diagnosed: Hyperactive-impulsive, affecting primarily boys; Inattentive, which includes a higher percentage of girls; and combined. The question has arisen concerning whether the use of prescribed stimulants predisposes kids to later drug abuse. According to Dr. Peter Breggin, Director of the International Center for the study of Psychiatry and Psychology, Methylphenidate, amphetamine, and cocaine affect the same neurotransmitter systems, and so use of Ritalin and similar drugs may result in use of illegal stimulants. Nadine Lambert has conducted research which showed that ADHD children medicated with stimulants are more likely to start using illegal drugs than are other children. However, a study by Biedermans, Wilens, et al found that medication for ADHD reduced the likelihood of later substance abuse. Letting young people speak for themselves in this matter (personal anecdotes from young acquaintances), it is quite clear that Ritalin, at least, has become a fashionable drug of abuse, although in some cases in a new and strangely disciplined fashion. An interesting article at a student-run website... From November 16-18, 1998, the National Institutes of
Health convened the Consensus Development Conference on Diagnosis and
Treatment of Attention Deficit Hyperactivity Disorder. The Consensus
Statement (28 sec @ 28k; worth reading!) concluded: Conclusions (for the time being): CLICK HERE FOR AN ENTIRELY DIFFERENT PERSPECTIVE.....
REFERENCES American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders, Fourth Edition (DSM-IV). Washington, D.C.: author. Barkley, Russell A (1997). ADHD and the Nature of Self-control (1997). New York: The Guilford Press. Breggin, P. (1998). Talking back to Ritalin: What doctors aren't telling you about stimulants for children. Monroe, Maine: Common Courage Press. Breggin, P. (1999a). Psychostimulants in the treatment of children diagnosed with ADHD: Part I: Acute risks and psychological effects. Ethical Human Sciences and Services, 1 13-33. Breggin, P. (1999b). Psychostimulants in the treatment of children diagnosed with ADHD: Part II: Adverse effects on brain and behavior. Ethical Human Sciences and Services, 1, 213-241. Breggin, P. (1999c). Psychostimulants in the treatment of children diagnosed with ADHD: Risks and mechanism of action. International Journal of Risk and Safety in Medicine, 12, 3-35. By special arrangement, this report was originally published in two parts by Springer Publishing Company in Ethical Human Sciences and Services (Breggin 1999a&b). Breggin, P. (2000). Reclaiming our children: A healing solution for a nation in crisis. Cambridge, Massachusetts: Perseus Books. Lambert, N. (1998). Stimulant treatment as a risk factor for nicotine use and substance abuse. Program and Abstracts, pp. 191-8. NIH Consensus Development Conference Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder. November 16-18, 1998. William H. Natcher Conference Center. National Institutes of Health. Bethesda, Maryland. Lambert, N., & Hartsough, C.S. (in press). Prospective study of tobacco smoking and substance dependence among samples of ADHD and non-ADHD subjects. Journal of Learning Disabilities. Zito, J.M., Safer, D .J., dosReis, S., Gardner, J.F., Boles, J., and Lynch, F. (2000). Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association, 283, 1025-1030.
|